References
- Kaptein MB, Hirasing RA, Koppenaal C, et al. Endocrine features of polycystic ovary syndrome in a random population sample of 14-16 year old adolescents[J]. Hum Reprod. 1999;14(9):2223–2229.
- Hoyt KL, Schmidt MC. Polycystic ovary(Stein-Leventha1)syn- drome: etiology, complications, and treatment [J]. Clin Lab Sci. 2004;17(3):155–163.
- Szczuko M, Zapałowskachwyć M, Maciejewska D, et al. High glycemic index diet in PCOS patients. The analysis of IGF I and TNF-α pathways in metabolic disorders.[J]. Medical Hypotheses. 2016;96:42–47.
- Uematsu S, Akira S. Toll-like receptors and innate immunity. J Mol Med (Berl). 2006;84(9):712–725.
- Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med. 2007;13(11):460͂469.
- Takeda K, Akira S. Microbial recognition by toll-like receptors. J Dermatol Sci. 2004(34):73–82.
- Brunn GJ, Bungum MK, Johnson GB, et al. Conditional signaling by Toll-like receptor 4. FASEB J. 2005;19(7):872–874.
- Bi X, Zhai Z, Wang S, et al. Identification of the key pathways and genes related to polycystic ovary syndrome using bioinformatics analysis. Gen Physiol Biophys. 2019 May;38(3):205–214.
- Vijay K. Toll-like receptors in immunity and inflammatory diseases: Past, present, and future. Int Immunopharmacol. 2018 Jun;59:391-412.
- Calore F, Londhe P, Fadda P, et al. The TLR7/8/9 antagonist IMO-8503 inhibits cancer-Induced Cachexia. Cancer Res. 2018 Dec;78(23):6680–6690.
- McDonald G, Cabal N, Vannier A, et al. Female bias in systemic lupus erythematosus is associated with the differential expression of X-Linked toll-Like receptor 8. Front Immunol. 2015;6:457.
- Bayraktar R, Bertilaccio MTS, Calin GA. The interaction between two worlds: microRNAs and toll-Like receptors. Front Immunol. 2019 May;14(10):1053.
- Gebremedhn S, Ali A, Hossain M, et al. MicroRNA-Mediated gene regulatory mechanisms in mammalian female reproductive health. Int J Mol Sci. 2021;22(2):938.
- Chen X, Liang H, Zhang J, et al. microRNAs are ligands of toll-like receptors. RNA. 2013 Jun;19(6):737–739.
- Naji M, Aleyasin A, Nekoonam S, et al. Differential expression of miR-93 and miR-21 in granulosa cells and follicular fluid of polycystic ovary syndrome associating with different phenotypes. Sci Rep. 2017;7(1):14671.
- Fabbri M, Paone A, Calore F, et al. MicroRNAs bind to toll-like receptors to induce prometastatic inflammatory response. Proceedings of the National Academy of Sciences of the United States of America. 2012;109:E2110–6.
- Preall JB, Sontheimer EJ. RNAi: RISC gets loaded. Cell. 2005;123(4): 543–545. 10.1016/j.cell.2005.11.006.
- Legro RS, Kunselman AR, Dunaif A, et al. Prevalence and pre- dictors of dyslipidemia in women with polycystic ovary syndrome [J]. Am J Med. 2001;111(8):607–613.
- Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–233.
- Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010;11(9):597–610.
- Marinelli C, Di Liddo R, Facci L, et al. Ligand engagement of Toll-like receptors regulates their expression in cortical microglia and astrocytes. J Neuroinflammation. 2015;12(1):244.
- Chen X, Liang H, Zhang J, et al. Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol. 2012;22(3):125–132.
- Chen X, Liang H, Zhang CY, et al. miRNA regulates noncoding RNA: a noncanonical function model. Trends Biochem Sci. 2012;37(11):457–459.
- Takeda K, Akira S. Toll-like receptors. Curr Protoc Immunol. 2015;109(1):142. 1.
- Pasare C, Medzhitov R. Toll-like receptors: linking innate and adaptive immunity[J]. Microbes & Infection. 2004;6(15):1382–1387.